We provide consultations and training regarding phages and phage therapies to healthcare professionals, veterinarians, and researchers. We work to promote the standardization of phage therapy in infectious disease treatment.
We supply a diverse range of phage therapy products against various human, poultry and bovine infections. These include phages against UTIs (Uropathogenic E. coli), skin infections (S. aureus) and diarrheagenic infections in humans, mastitis in livestock and colibacillosis (Avian Pathogenic E. coli; APEC) in poultry.
We offer solutions against infections by MDR bacterial pathogens, thereby reducing the excessive and inefficient use of antibiotics and preventing the spread of antibiotic-resistant bacterial strains
We develop customized phage cocktails against specific bacterial strains identified in the samples provided, to ensure effective and accurate phage therapies.
We use reliable and accurate methods to determine pathogenic bacterial strain identification and characterization in the samples. This enables us to develop the most effective phage treatment against infections.
We offer fast, efficient and precise microbial testing and analysis of various sources, particularly human, poultry and bovine.
